company background image
524518 logo

Krebs Biochemicals & Industries BSE:524518 Stock Report

Last Price

₹98.53

Market Cap

₹2.1b

7D

19.6%

1Y

23.0%

Updated

25 Nov, 2024

Data

Company Financials

Krebs Biochemicals & Industries Limited

BSE:524518 Stock Report

Market Cap: ₹2.1b

524518 Stock Overview

Engages in the manufacture and sale of active pharmaceutical ingredients in India. More details

524518 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Krebs Biochemicals & Industries Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Krebs Biochemicals & Industries
Historical stock prices
Current Share Price₹98.53
52 Week High₹121.50
52 Week Low₹60.00
Beta0.45
11 Month Change26.24%
3 Month Change18.71%
1 Year Change23.01%
33 Year Change-40.82%
5 Year Change7.62%
Change since IPO-63.93%

Recent News & Updates

Recent updates

Shareholder Returns

524518IN PharmaceuticalsIN Market
7D19.6%2.3%2.4%
1Y23.0%43.8%29.5%

Return vs Industry: 524518 underperformed the Indian Pharmaceuticals industry which returned 42.5% over the past year.

Return vs Market: 524518 underperformed the Indian Market which returned 27.5% over the past year.

Price Volatility

Is 524518's price volatile compared to industry and market?
524518 volatility
524518 Average Weekly Movement7.6%
Pharmaceuticals Industry Average Movement6.2%
Market Average Movement6.1%
10% most volatile stocks in IN Market9.1%
10% least volatile stocks in IN Market4.0%

Stable Share Price: 524518's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: 524518's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
1991191Jitendra Shahkrebsbiochem.com

Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications.

Krebs Biochemicals & Industries Limited Fundamentals Summary

How do Krebs Biochemicals & Industries's earnings and revenue compare to its market cap?
524518 fundamental statistics
Market cap₹2.12b
Earnings (TTM)-₹217.56m
Revenue (TTM)₹506.94m

4.2x

P/S Ratio

-9.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524518 income statement (TTM)
Revenue₹506.94m
Cost of Revenue₹106.58m
Gross Profit₹400.36m
Other Expenses₹617.92m
Earnings-₹217.56m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-10.09
Gross Margin78.98%
Net Profit Margin-42.92%
Debt/Equity Ratio-157.2%

How did 524518 perform over the long term?

See historical performance and comparison